Roderick Wong is the founder and Managing Partner/Chief Investment Officer of RTW Investments. See sector focus.
Roderick Wong is the founder and Managing Partner/Chief Investment Officer of RTW Investments, the New York-based life sciences investment firm he launched in 2009; SEC filings also identify him as an Executive Officer of RTW Innovation Offshore Fund Ltd. RTW says it invests in innovative drug development and builds a team to identify scientific breakthroughs and turn them into medicine, with the firm’s activity centered on healthcare and biotech/medtech innovation. Public descriptions indicate RTW operates as a full-lifecycle investor spanning early-stage to later-stage companies, but the available sources do not give a verified standard check size or clear lead-versus-follow policy. Named portfolio or holding-company examples tied to Wong and RTW in the sources include Immunovant, Rocket Pharmaceuticals, Verona Pharma, and Beta Bionics. Wong has also been publicly featured discussing biotech investing and innovation. He holds an MD/MBA from Penn and Harvard and has emphasized educating life science entrepreneurs and supporting health equity through the RTW Foundation.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in New York.
Investors like Roderick Wong · Full investor directory · Investor access · Company funding database